Seelos Therapeutics stock analysis
Want to see SEELQ full AI Analyst Report?
Seelos Therapeutics (SEELQ) Stock Price & Analysis
SEELQ Stock Chart & Stats
- Day’s Range
- $0.18 - $0.18
- 52-Week Range
- $0.18 - $0.18
- Previous Close
- $0.18
- Volume
- N/A
- Average Volume (3M)
- 423
- Market Cap
- $1
- Enterprise Value
- $11.36T
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- $147.00K
- Price to Earnings (P/E)
- ―
- Beta
- -25.17
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Pipeline Potential
Seelos' focus on CNS disorders and rare diseases positions it well in niche markets with high unmet needs, potentially leading to successful drug approvals and partnerships.
Revenue Generation Strategy
The company's strategy to generate revenue through strategic partnerships and licensing agreements can provide financial support and enhance its R&D capabilities.
Gross Profit Margin
A 100% gross profit margin indicates effective cost management in its operations, which is crucial for sustaining profitability once products are commercialized.
Bears Say
Negative Stockholders' Equity
Negative equity suggests liabilities exceed assets, posing solvency risks and necessitating financial restructuring to ensure long-term viability.
Cash Flow Challenges
Ongoing negative cash flow indicates persistent cash outflows, which could threaten sustainability without new financing or successful product commercialization.
Operational Losses
Significant operational losses highlight inefficiencies and the need for cost management improvements to achieve profitability and long-term growth.
SEELQ FAQ
What was Seelos Therapeutics’s price range in the past 12 months?
What is Seelos Therapeutics’s market cap?
When is Seelos Therapeutics’s upcoming earnings report date?
How were Seelos Therapeutics’s earnings last quarter?
Is Seelos Therapeutics overvalued?
Does Seelos Therapeutics pay dividends?
What is Seelos Therapeutics’s EPS estimate?
How many shares outstanding does Seelos Therapeutics have?
What happened to Seelos Therapeutics’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Seelos Therapeutics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Seelos Therapeutics
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Raj Mehra
- Employees
- 16
- Website
- www.seelostherapeutics.com
- Address
- 300 Park Avenue,12th Floor, New York, NY, 10022, US
Seelos Therapeutics (SEELQ) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 2 |
| Technical Analysis | 0 | 1 | 0 |
| Moving Averages | 4 | 2 | 2 |

